Role of herbal medicine and gut microbiota in the prevention and treatment of obesity

被引:19
作者
Zhang, Qiao [1 ,3 ]
Bai, Yaya [1 ]
Wang, Wenxiao [1 ]
Li, Jiajia [1 ]
Zhang, Li [2 ]
Tang, Yuping [1 ]
Yue, Shijun [1 ,3 ]
机构
[1] Shaanxi Univ Chinese Med, Shaanxi Collaborat Innovat Ctr Chinese Med Resourc, Key Lab Shaanxi Adm Tradit Chinese Med TCM Compati, State Key Lab Res & Dev Characterist Qin Med Resou, Xian 712046, Peoples R China
[2] Nanjing Univ Chinese Med, Hanlin Coll, Taizhou 225300, Jiangsu, Peoples R China
[3] Shaanxi Univ Chinese Med, Shiji Ave, Xian 712046, Peoples R China
关键词
Obesity; Gut microbiota; Herbal medicine; Mechanism; Short chain fatty acids; HIGH-FAT-DIET; TRADITIONAL CHINESE MEDICINE; INSULIN-RESISTANCE; INTESTINAL MICROBIOTA; HOST PHYSIOLOGY; ADIPOSE-TISSUE; BRAIN AXIS; MICE; MODULATION; INFLAMMATION;
D O I
10.1016/j.jep.2022.116127
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Obesity is a common metabolic dysfunction disease, which is highly correlated with the homeostasis of gut microbiota (GM). The dysregulation of GM on energy metabolism, immune response, insulin resistance and endogenous metabolites (e.g., short chain fatty acids and secondary bile acids) can affect the occurrence and development of obesity. Herbal medicine (HM) has particular advantages and definite therapeutic effects in the prevention and treatment of obesity, but its underlying mechanism is not fully clear.Aim of the study: In this review, the representative basic and clinical anti-obesity studies associated with the homeostasis of GM regulated by HM including active components, single herb and herbal formulae were sum-marized and discussed. We aim to provide a state of art reference for the mechanism research of HM in treating obesity and the further development of new anti-obesity drugs.Materials and methods: The relevant information was collected by searching keywords (obesity, herbal medicine, prescriptions, mechanism, GM, short chain fatty acids, etc.) from scientific databases (CNKI, PubMed, Spring-erLink, Web of Science, SciFinder, etc.).Results: GM dysbiosis did occur in obese patients and mice, whiles the intervention of GM could ameliorate the condition of obesity. HM (e.g., berberine, Ephedra sinica, Rehjnannia glutinosa, and Buzhong Yiqi prescription) has been proved to possess a certain regulation on GM and an explicit effect on obesity, but the exact mechanism of HM in improving obesity by regulating GM remains superficial. Conclusion: GM is involved in HM against obesity, and GM can be a novel therapeutic target for treating obesity.
引用
收藏
页数:14
相关论文
共 162 条
  • [1] Gut Microbiota and Obesity: A Role for Probiotics
    Abenavoli, Ludovico
    Scarpellini, Emidio
    Colica, Carmela
    Boccuto, Luigi
    Salehi, Bahare
    Sharifi-Rad, Javad
    Aiello, Vincenzo
    Romano, Barbara
    De Lorenzo, Antonino
    Izzo, Angelo A.
    Capasso, Raffaele
    [J]. NUTRIENTS, 2019, 11 (11)
  • [2] Recent developments in the probiotics as live biotherapeutic products (LBPs) as modulators of gut brain axis related neurological conditions
    Agagunduz, Duygu
    Gencer Bingol, Feray
    Celik, Elif
    Cemali, Ozge
    Ozenir, Ciler
    Ozogul, Fatih
    Capasso, Raffaele
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [3] Microbiota alteration and modulation in Alzheimer's disease by gerobiotics: The gut-health axis for a good mind
    Agagunduz, Duygu
    Kocaadam-Bozkurt, Betul
    Bozkurt, Osman
    Sharma, Heena
    Esposito, Renata
    Ozogul, Fatih
    Capasso, Raffaele
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2022, 153
  • [4] Regulation of adipokine production in human adipose tissue by propionic acid
    Al-Lahham, Sa'ad H.
    Roelofsen, Han
    Priebe, Marion
    Weening, Desiree
    Dijkstra, Martijn
    Hoek, Annemieke
    Rezaee, Farhad
    Venema, Koen
    Vonk, Roel J.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2010, 40 (05) : 401 - 407
  • [5] Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
    Aron-Wisnewsky, Judith
    Vigliotti, Chloe
    Witjes, Julia
    Le, Phuong
    Holleboom, Adriaan G.
    Verheij, Joanne
    Nieuwdorp, Max
    Clement, Karine
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2020, 17 (05) : 279 - 297
  • [6] Bai RB, 2022, FOOD FUNCT, V13, P8143, DOI [10.1039/d2fo01119k, 10.1039/D2FO01119K]
  • [7] Ginsenoside Rb1, salvianolic acid B and their combination modulate gut microbiota and improve glucolipid metabolism in high-fat diet induced obese mice
    Bai, Ying
    Bao, Xueli
    Mu, Qianqian
    Fang, Xin
    Zhu, Ruyuan
    Liu, Chenyue
    Mo, Fangfang
    Zhang, Dongwei
    Jiang, Guangjian
    Li, Ping
    Gao, Sihua
    Zhao, Dandan
    [J]. PEERJ, 2021, 9
  • [8] Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice
    Cani, Patrice D.
    Bibiloni, Rodrigo
    Knauf, Claude
    Neyrinck, Audrey M.
    Neyrinck, Audrey M.
    Delzenne, Nathalle M.
    Burcelin, Remy
    [J]. DIABETES, 2008, 57 (06) : 1470 - 1481
  • [9] Targeting microbiota in dietary obesity management: a systematic review on randomized control trials in adults
    Caputo, Marina
    Pigni, Stella
    Antoniotti, Valentina
    Agosti, Emanuela
    Caramaschi, Alice
    Antonioli, Alessandro
    Aimaretti, Gianluca
    Manfredi, Marcello
    Bona, Elisa
    Prodam, Flavia
    [J]. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2023, 63 (33) : 11449 - 11481
  • [10] Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota
    Chang, Chih-Jung
    Lin, Chuan-Sheng
    Lu, Chia-Chen
    Martel, Jan
    Ko, Yun-Fei
    Ojcius, David M.
    Tseng, Shun-Fu
    Wu, Tsung-Ru
    Chen, Yi-Yuan Margaret
    Young, John D.
    Lai, Hsin-Chih
    [J]. NATURE COMMUNICATIONS, 2015, 6